Conducting Phase I Trials During the SARS-Coronavirus-2 Outbreak: About Science and Care
Front Oncol
.
2020 May 22:10:926.
doi: 10.3389/fonc.2020.00926.
eCollection 2020.
Authors
Angelo Dipasquale
1
2
,
Pasquale Persico
1
2
,
Elena Lorenzi
2
,
Monica Bertossi
2
,
Armando Santoro
1
2
,
Matteo Simonelli
1
2
Affiliations
1
Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.
2
Humanitas Cancer Center, Humanitas Clinical and Research Center-IRCCS, Rozzano, Italy.
PMID:
32574280
PMCID:
PMC7256652
DOI:
10.3389/fonc.2020.00926
No abstract available
Keywords:
COVI-19; Cancer; Phase I (drug development); SARS - CoV-2; clinical trial.